Author

Raisa I. Krutilina

Tulane UniversityORCID 0000-0002-2118-4019Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

Hilaire C. PlayaiD· 2 shared Tiffany Nicole SeagrovesiD· 2 shared Alexandra Cullom· 1 shared Bernd MeibohmiD· 1 shared Bhargavi ThalluriiD· 1 shared Carol Ann LangeiD· 1 shared Caroline H. DiepiD· 1 shared Damilola OluwalanaiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Hilaire C. PlayaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mineralocorticoid and glucocorticoid receptor interaction drives TGFB1-induced triple-negative breast cancer progression to metastasis

Sai Harshita Posani, Caroline H. Diep, Raisa I. Krutilina, Hilaire Smith, Tiffany Nicole Seagroves, John Blenis, Carol Ann Lange

This study shows that mineralocorticoid receptor (MR) and phosphorylated glucocorticoid receptor (p-GR) interaction promotes triple-negative breast cancer (TNBC) metastasis through migratory, stemness, and fibrotic mechanisms.

bioRxiv · Nov 3, 2025 · PreprintCancer Biology

Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer

Damilola Oluwalana, Kelli L. Adeleye, Raisa I. Krutilina, Hao Chen, Hilaire C. Playa, Shanshan Deng, Deanna N. Parke, John Abernathy, Leona Middleton, Alexandra Cullom, Bhargavi Thalluri, Dejian Ma, Bernd Meibohm, Duane D. Miller, Tiffany Nicole Seagroves, Wěi Li

This study evaluates the biological activity of 60c, a next-generation colchicine-binding site inhibitor, showing improved potency and anti-metastatic effects in triple-negative breast cancer models.

Cancer Letters · May 23, 2024Peer-reviewedCancer Biology